We use cookies to ensure that we give you the best experience on our website. Read privacy policies.
In a significant advancement, researchers at the Broad Institute, led by James Collins, have harnessed artificial intelligence to identify new potential antibiotics. Using deep learning, they screened millions of compounds and tested those with promise in mice, finding several that effectively combat drug-resistant pathogens like MRSA. This research, building upon earlier work in the field, including contributions from César de la Fuente of the University of Pennsylvania, also explores explainable AI to better understand the biochemistry involved in antibiotic efficacy. The discovery holds promise for developing new treatments against resistant bacterial infections.
New Class of Antibiotics Discovered Using AI
Thank you for subscribing!